Please login to the form below

Not currently logged in
Email:
Password:

Katja Stout joins Citigate Dewe Rogerson

The former AstraZeneca vice president will serve as a director in its life sciences team

Citigate Dewer Rogerson Katja StoutCitigate Dewe Rogerson has appointed former AstraZeneca vice president Katja Stout as a director in its life sciences team.

She was previously MD and founder at Scius Communications, prior to which she served as  vice president, corporate affairs, global product and portfolio strategy at AstraZeneca, where she was responsible for global brand communications and established Its partnering communications function. 

In addition to working in-house for several biotech companies and venture capital firms, Stout co-founded specialist life sciences communications firm Northbank communications, which was subsequently sold to College Hill (now Instinctif Partners).  

David Dible, senior director and head of Citigate's life sciences team, said: “Katja brings a wealth of experience in strategic communications in the life sciences sector that will complement and enhance our offering to companies of all sizes.  

“She joins a growing team focused on building an international operation that can offer expertise across the spectrum of communications for early stage companies through to major pharmaceutical businesses.”

10th December 2015

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics